Trials / Completed
CompletedNCT00929500
Exercise Program in Women With Metabolic Syndrome
The Effect of Mixed Aerobic and Strength Training Program on Physical Fitness and Cerebrovascular Function in Older Women With Metabolic Syndrome: A Pilot Study With Randomized Control Trial (RCT) Design
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- Female
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.
Detailed description
Metabolic syndrome is a cluster of conditions and disorders that increase the risk for coronary artery disease (CAD) and strokes. Sedentary lifestyle is one of the risk factors, which decrease overall physical fitness and together with aging may lead to decrease in physical functioning in everyday life as well as changes in blood flow in the brain and cognitive functions. Regular physical activity is associated with a reduced risk of cardiovascular disease. It may also improve blood flow velocity and cognitive functions. Physical activity should be as effective as possible, but also as safe as possible. Supervised mixed aerobic and strength training (MAST) program for 4 months enables to individualize the intensity of aerobic exercise based on measured maximal exercise capacity. Throughout each training session heart rate will be monitored with a new real time wireless ECG system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MAST program | MAST program: twice a week for 4 months |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-05-01
- Completion
- 2013-12-01
- First posted
- 2009-06-29
- Last updated
- 2017-11-13
- Results posted
- 2017-09-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00929500. Inclusion in this directory is not an endorsement.